Skip to main content
Fig. 7 | Stem Cell Research & Therapy

Fig. 7

From: Intranasal delivery of hMSC-derived supernatant for treatment of ischemic stroke by inhibiting the pro-inflammatory polarization of neutrophils

Fig. 7

hMSCs activate PPAR-γnuclear translocation to promote N2-type neutrophil polarization in vitro. A, B: Western Blot analysis of nuclear PPAR-γ protein expression and statistical analysis. C, D: Western Blot analysis of cytoplasmic PPAR-γ, total PPAR-γ, and phosphorylated PPAR-γ expression and statistical analysis. E, F: Flow cytometry analysis of the proportion of N2 (Ly6G+CD206+) and N1 (Ly6G+iNOS+) neutrophils. G: ELISA analysis of the secretion level of IL-10 and TGF-β in N2-type neutrophils. n = 5, vs PMA *P < 0.05, **P < 0.01, ***P < 0.001. PMA + L + inhibitior versus PMA + L ##P < 0.01, ###P < 0.001. PMA + M + inhibitior versus PMA + M $P < 0.01, $$P < 0.01, $$$P < 0.001

Back to article page